IONS vs LBRX · rev $514.0M vs $803.4M cap
Ionis Pharmaceuticals Inc (IONS) versus LB Pharmaceuticals Inc Common Stock (LBRX) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
LB Pharmaceuticals Inc Common Stock (LBRX) is a biotechnology company listed on NASDAQ.
Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.
LBRX does not have a complete income-statement cache yet.
IONS currently screens at market cap $12.28B. LBRX currently screens at market cap $803.4M.
Not investment advice. Open the IONS and LBRX stock pages for the full models.
Not investment advice.